Prescription Use of Paracetamol During Pregnancy and Risk of Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder in Early Childhood
Abstract
Objective: Paracetamol is the drug of choice for treating pain and fever during pregnancy. Concerns exist regarding risk of neurodevelopmental disorders in prenatally exposed offspring, especially autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD). Since September 2013, most paracetamol sales in Denmark have been prescription based, enabling investigation in a population-based setting. We investigated the association between prescription-based paracetamol use during pregnancy and the risk of clinically diagnosed ASD and ADHD detected in early childhood among exposed offspring.
Method: We included all singleton children live-born between October 1, 2014, and December 31, 2021 and their linked mothers using Danish nationwide health registers. Exposure was defined as ≥1 prescriptions redeemed for paracetamol during pregnancy. Children were followed up until 6 years of age or the end of the study period (December 31, 2022). Using a triangulation approach, we did the following: (1) compared exposed children to unexposed children; (2) compared exposed children to children of mothers who redeemed prescriptions before, but not during, pregnancy; and (3) used a paternal negative-exposure group.
Results: Adjusted risk ratios (aRR) for ASD and ADHD at 6 years of age among exposed children compared to unexposed children were 1.15 (95% CI = 0.96-1.39) and 1.09 (95% CI = 0.85-1.40), respectively. No increased risks were observed when comparing to children…
Read the paper
Related studies
- Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial
- Effect of a Postoperative Multimodal Opioid-Sparing Protocol vs Standard Opioid Prescribing on Postoperative Opioid Consumption After Knee or Shoulder Arthroscopy: A Randomized Clinical Trial
- Comparison of the Post-Caesarean Analgesic Effect of Adding Dexmedetomidine to Paracetamol and Ketorolac: A Randomized Clinical Trial
- A triple-blind randomized clinical trial of different associations between dexamethasone and non-steroids anti-inflammatories for preemptive action in third molar extractions
- An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
- Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: Single centre double-blind, randomised controlled clinical trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.